Modulation of metabolic, inflammatory, fibrotic, and cell death pathways by resmetirom in metabolic

Chen-Yang He1, Zhi-Hua Wang1, Jian-Ping Weng1,2,3

  • 1Department of Endocrinology and Metabolism, Centre for Leading Medicine and Advanced Technologies of IHM, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, China.

Acta Pharmacologica Sinica
|February 19, 2026
PubMed
Abstract

No abstract available in PubMed .